Clinical Handbook of Psychotropic Drugs, 23rd edition available in Other Format
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
• Independent, unbiased, up-to-date – now with Spravato (esketamine)
• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
• Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
• Potential interactions and side effects summarized in comparison charts
• With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
• Clearly written patient information sheets available for download as printable PDF files
New in this edition
• Antipsychotics updates include new section on 5-HT2A inverse agonist antipsychotic (pimavanserin, Nuplazid) and comprehensive revision of augmentation strategies
• Antidepressants revised, including updates to use in pregnancy and SPARI drug interactions
• Pharmacogenomics chapter fully revised with expanded dose adjustment recommendations
• Chart of agents under investigation for treatment of substance use disorders fully revised, new agents include lofexidine (Lucemyra), Kadian, nortriptyline e-cigarettes
• Unapproved treatments chapter with significant updates, including new sections on adrenergic agents in PTSD (doxazocine), antiflammatory agents in depression (pioglitazone, rosiglitazone, statins), and hormones in schizophrenia (raloxifene)
• Expanded treatment options for extrapyramidal side effects include deutetrabenazine and valbenazine
• New formulations and trade names include: Spravato (esketamine), as well as Adzenys ER, Aristada, Austedo, Cotempla XR-ODT, Fanatrex FusePaq, Foquest, Ingrezza, Jornay PM, Mydayis, Nuplazid, Sublocade, Zelapar
This book is a must for everyone who needs an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.
From the reviews:
"The Clinical Handbook of Psychotropic Drugs is a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. The handbook is continually updated and provides current evidence-based and clinically relevant information to optimize patient care. The contents are independent and unbiased, with easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions, etc.) providing a quick overview of treatment options."
Barry G. Woodcock, in International Journal of Clinical Pharmacology & Therapeutics, vol. 55, 2017
"[T]his book should be on the desk of every physician."
Psychotherapy and Psychosomatics, September 2017
"A user-friendly and practical resource guide to using psychotropic drugs in any setting... The handbook is well organized and covers almost every treatment used in psychiatry, arranged by disease state and class. Each medicine or class of medicine is subjected to a thorough review of nearly everything one should understand. It is easy to read and/or reference quick information. The comprehensive information on each class of drugs is what makes this book so useful. As a psychiatrist who routinely prescribes medications, I find this handbook invaluable."
Corey Goldstein, MD, Rush University Medical Center, in Doody's Listings and Reviews, 2016
"The new edition of this reference textbook about psychotropic drugs remains as useful as ever, and is essential for any medicines information department.
It is thorough, detailed and extensive, but the information is clear and concise and the book is easy to navigate because of its consistent, methodical and ordered format. The material is tabulated and clearly displayed throughout using colour coding, icons and symbols, making it simple to use.
Caroline Parker, MPharmS, consultant pharmacist, mental health services, at Central and North West London NHS Foundation Trust, in The Pharmaceutical Journal, 2015
“A powerhouse of practical information ... packed with well-researched monographs and comparative tables that are both detailed and succinct. Unrivalled in scope ... For practitioners encountering unfamiliar treatment scenarios, the section on yet-to-be-approved new psychiatric therapies will be particularly useful and is not easily found elsewhere. The sections on switching and augmentation strategies ... provide invaluable guidance. Drugs are fully indexed by generic and brand name and by class. Coloured icons make it easier to locate specific parcels of information. This outstanding and unique handbook is as rich in useful content as many full textbooks.”
Barbara Jovaisas, clinical editor at the Canadian Pharmacists Association and staff pharmacist at the Ottawa Hospital, Ottawa, Ontario, in Canadian Pharmacists Journal
“The best handbook of psychotropics I’ve ever read. Practical, succinct, and better than anything else available. The comparison charts are easy to use and unique to this handbook and help me select the right medication for the patient.”
Carl Anderson, MD, Private Practice, Bronx, NY
“An invaluable quick reference guide for the busy clinician.”
B. E. Leonard in Human Psychopharmacology: Clinical and Experimental
“Comprehensive… clearly and consistently organized… an ideal resource for rapid and straight-forward retrieval of essential clinical information… a ‘must have’ for those who work in mental health care.”
Marshall Cates, PharmD, in Annals of Pharmacotherapy
“Should be available at all nursing stations.”
C. Lindsay DeVane, PharmD, in American Journal of Health Systems Pharmacy
|Publisher:||Hogrefe & Huber Publishers|
|Product dimensions:||9.10(w) x 10.80(h) x 1.00(d)|
About the Author
Ric M. Procyshyn; BScPharm, MSc, PharmD, PhD; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; British Columbia Mental Health & Addictions Research Institute, Vancouver, BC, Canada. Kalyna Z. Bezchlibnyk-Butler; BScPharm, FCSHP; Toronto, ON, Canada. J. Joel Jeffries; MB, FRCPC, DFCPA; Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada."